已完本玄幻小说排行榜,完美世界辰东,武道至尊帝临小说

日韩精品免费播放_国内黄色一级精品_久久五月丁香合缴_67194日韩熟妇在线进入_国产一区二区三级在线观看_太大太长又硬放进去很爽_snowdaze汉化版巴比伦_桃色aV免费网站_色即是空甜性涩爱_亚洲?V无码乱码国产精品

重組Anti-FOXP3抗體[EPR22102-37] (ab215206)

品牌：Abcam

產(chǎn)地：英國(guó)

型號(hào)：100ul

貨號(hào)：ab215206

發(fā)布日期： 2023-05-29
更新日期： 2024-11-07

發(fā)送咨詢信息

產(chǎn)品詳請(qǐng)

產(chǎn)地	英國(guó)
品牌	Abcam
保存條件	Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
貨號(hào)	ab215206
用途
應(yīng)用范圍
抗原來(lái)源
保質(zhì)期
抗體名	兔單克隆抗體[EPR22102-37] to FOXP3
是否單克隆
克隆性
靶點(diǎn)
適應(yīng)物種
形態(tài)
宿主	Rabbit
標(biāo)記物
包裝規(guī)格	100ul
亞型
標(biāo)識(shí)物
濃度	批次濃度范圍 100 μl 濃度為 0.367 - 0.408 mg/ml 批次濃度范圍 40 μl 濃度為 0.39 - 0.408 mg/ml 批次濃度范圍 10 μl 濃度為 0.367 - 0.408 mg/ml%
免疫原	Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
是否進(jìn)口

產(chǎn)品名稱

Anti-FOXP3抗體[EPR22102-37]
參閱全部 FOXP3 一抗
描述

兔單克隆抗體[EPR22102-37] to FOXP3
宿主

Rabbit
特異性

The rat recommendation is based on the IHC results. We do not guarantee WB for rat.

According to our preliminary WB data, this antibody failed to detect endogenous expression of FOXP3 in the tissues tested in WB, such as thymus. It might work in CD4+CD25+ Treg cells with abundant FOXP3, but we don’t have experimental data to support that.
經(jīng)測(cè)試應(yīng)用

適用于: WB, IP, IHC-P, Flow Cyt (Intra), mIHCmore details
不適用于: ICC/IF or IHC-Fr
種屬反應(yīng)性

與反應(yīng): Mouse, Rat, Human
免疫原

Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
陽(yáng)性對(duì)照
- WB: HEK-293T transfected with FOXP3 (WT) expression vector with a GFP-myc tag, whole cell lysate. Full-length C-MYC/DDK tagged Recombinant Mouse Foxp3 protein. IHC-P: Human, mouse, rat thymus tissues, human and mouse spleen tissues, human tonsil tissue. Flow Cyt (intra): HEK-293T transfected with a GFP-tagged FOXP3 expression construct. IP: HEK-293T transfected with a GFP-tagged FOXP3 expression construct whole cell lysate.
常規(guī)說(shuō)明
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
For more information see here .
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents .